TY  - JOUR
AU  - de Alava, Enrique
AU  - Pareja, María Jesús
AU  - Carcedo, David
AU  - Arrabal, Natalia
AU  - García, José-Francisco
AU  - Bernabé-Caro, Reyes
PY  - 2022
DO  - 10.1080/14737167.2022.2078310
UR  - http://hdl.handle.net/10668/19681
T2  - Expert review of pharmacoeconomics & outcomes research
AB  - To assess the cost-effectiveness of using next-generation sequencing (NGS) compared to sequential single-testing (SST) for molecular diagnostic and treatment of patients with advanced non-small cell lung cancer (NSCLC) from a Spanish single-center...
LA  - en
KW  - Non-small cell lung cancer (NSCLC)
KW  - cost-effectiveness
KW  - molecular profiling
KW  - next-generation sequencing
KW  - oncogenic drivers
KW  - sequential single testing
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Cost-Benefit Analysis
KW  - High-Throughput Nucleotide Sequencing
KW  - Hospitals
KW  - Humans
KW  - Lung Neoplasms
KW  - Mutation
TI  - Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.
TY  - research article
VL  - 22
ER  -